Form D · Pharmaceuticals

Dicerna Pharmaceuticals Inc

Watertown, MA · CIK 0001399529

Offering snapshot reported Aug 15, 2013 · SEC filing

Reported sold
$60M
Offering amount: $63M
Investors reported
13
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jul 30, 2013
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 15, 2013Initial$59,999,937No comparison13SEC filing
Oct 28, 2010Amendment$29,050,628$4,250,000vs Aug 19, 201010SEC filing
Aug 19, 2010Initial$24,800,628No comparison9SEC filing
Jun 28, 2010Initial$5,000,000No comparison4SEC filing
May 1, 2007PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-201363
$63,000,000 is the maximum total and $3,000,063 the maximum remaining authorized for sale under the current Certificate of Incorporation.

Source: Form D, filed Aug 15, 2013. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Douglas Fambrough Director, Executive
Brian K. Halak Director
Stephen Hoffman Director
James C. Jenson Director
Peter Kolchinsky Director
Dennis H. Langer Director
Jonathan Mac Quitty Director
David Madden Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
480 Arsenal St. Building 1, Suite 120
Watertown, MA, 02472